Search Results

There are 21947 results for: content related to: Metabolite profiling of CHO cells with different growth characteristics

  1. New combined treatment of hypermelanosis: analytical studies on efficacy and stability improvement

    International Journal of Cosmetic Science

    Volume 23, Issue 6, December 2001, Pages: 333–340, V. Ferioli, C. Rustichelli, G. Pavesi and G. Gamberini

    Version of Record online : 7 OCT 2008, DOI: 10.1046/j.1467-2494.2001.00099.x

  2. Adaptation of CHO cells in serum-free conditions for erythropoietin production: Application of EVOP technique for process optimization

    Biotechnology and Applied Biochemistry

    Volume 63, Issue 5, September/October 2016, Pages: 633–641, Suzana Jukić, Dijana Bubenik, Nediljko Pavlović, Ana Jurinjak Tušek and Višnja Gaurina Srček

    Version of Record online : 18 APR 2016, DOI: 10.1002/bab.1468

  3. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants

    Biotechnology Journal

    Volume 9, Issue 4, April 2014, Pages: 566–577, Johannes F. Buyel and Rainer Fischer

    Version of Record online : 24 FEB 2014, DOI: 10.1002/biot.201300548

  4. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures

    The Journal of Gene Medicine

    Volume 11, Issue 10, October 2009, Pages: 868–876, Sven Ansorge, Stéphane Lanthier, Julia Transfiguracion, Yves Durocher, Olivier Henry and Amine Kamen

    Version of Record online : 20 JUL 2009, DOI: 10.1002/jgm.1370

  5. Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts

    Medicinal Research Reviews

    Volume 37, Issue 4, July 2017, Pages: 860–906, Sofia Esteves, Sara Duarte-Silva and Patrícia Maciel

    Version of Record online : 21 NOV 2016, DOI: 10.1002/med.21425

  6. You have free access to this content
    The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

    Journal of Neurochemistry

    Volume 110, Issue 6, September 2009, Pages: 1737–1765, Peter O. Bauer and Nobuyuki Nukina

    Version of Record online : 23 JUL 2009, DOI: 10.1111/j.1471-4159.2009.06302.x

  7. You have free access to this content
    Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets

    IUBMB Life

    Volume 64, Issue 11, November 2012, Pages: 879–884, Raj Kumar

    Version of Record online : 29 SEP 2012, DOI: 10.1002/iub.1088

  8. Local protein unfolding and pathogenesis of polyglutamine-expansion diseases

    Proteins: Structure, Function, and Bioinformatics

    Volume 51, Issue 1, 1 April 2003, Pages: 68–73, Yu Wai Chen

    Version of Record online : 8 FEB 2003, DOI: 10.1002/prot.10325

  9. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases


    Volume 20, Issue 4, December 2000, Pages: 326–333, Takayoshi Shimohata, Osamu Onodera and Shoji Tsuji

    Version of Record online : 7 JUL 2008, DOI: 10.1111/j.1440-1789.2000.00350.x

  10. Pathogenesis of Polyglutamine Diseases

    Standard Article


    Maria Pennuto and Fabio Sambataro

    Published Online : 15 DEC 2010, DOI: 10.1002/9780470015902.a0021486

  11. Polyglutamine homopolymers having 8–45 residues form slablike β-crystallite assemblies

    Proteins: Structure, Function, and Bioinformatics

    Volume 61, Issue 2, 1 November 2005, Pages: 398–411, Deepak Sharma, Leonid M. Shinchuk, Hideyo Inouye, Ronald Wetzel and Daniel A. Kirschner

    Version of Record online : 19 AUG 2005, DOI: 10.1002/prot.20602

  12. You have free access to this content
    Levels of supramolecular chirality of polyglutamine aggregates revealed by vibrational circular dichroism

    FEBS Letters

    Volume 587, Issue 11, June 05, 2013, Pages: 1638–1643, Dmitry Kurouski, Karunakar Kar, Ronald Wetzel, Rina K. Dukor, Igor K. Lednev and Laurence A. Nafie

    Version of Record online : 10 APR 2013, DOI: 10.1016/j.febslet.2013.03.038

  13. Intracranial Computed Tomography Angiography (CTA)

    Vascular Imaging of the Central Nervous System: Physical Principles, Clinical Applications, and Emerging Techniques

    Isabel R. Fragata, Joana N. Ramalho, Pages: 83–109, 2013

    Published Online : 30 NOV 2013, DOI: 10.1002/9781118434550.ch5

  14. Use of the NucliSENS EasyQHPV assay in the management of cervical intraepithelial neoplasia

    Journal of Medical Virology

    Volume 85, Issue 7, July 2013, Pages: 1235–1241, Ana Oliveira, Nuno Verdasca and Ângela Pista

    Version of Record online : 22 MAY 2013, DOI: 10.1002/jmv.23590

  15. You have free access to this content
    Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT

    The EMBO Journal

    Volume 29, Issue 20, October 20, 2010, Pages: 3459–3469, Naoki Hayashida, Mitsuaki Fujimoto, Ke Tan, Ramachandran Prakasam, Toyohide Shinkawa, Liangping Li, Hitoshi Ichikawa, Ryosuke Takii and Akira Nakai

    Version of Record online : 10 SEP 2010, DOI: 10.1038/emboj.2010.225

  16. You have free access to this content
    Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia

    EMBO reports

    Volume 9, Issue 4, April 2008, Pages: 393–399, Takashi Torashima, Chiho Koyama, Akira Iizuka, Kazuhiro Mitsumura, Kiyohiko Takayama, Shigeru Yanagi, Miho Oue, Haruyasu Yamaguchi and Hirokazu Hirai

    Version of Record online : 14 MAR 2008, DOI: 10.1038/embor.2008.31

  17. Time course of polyglutamine aggregate body formation and cell death: Enhanced growth in nucleus and an interval for cell death

    Journal of Neuroscience Research

    Volume 68, Issue 4, 15 May 2002, Pages: 442–448, I. Toyoshima, M. Sugawara, K. Kato, C. Wada, T. Shimohata, R. Koide, O. Onodera and S. Tsuji

    Version of Record online : 29 APR 2002, DOI: 10.1002/jnr.10233

  18. High-Throughput Screen of Natural Product Extracts in A Yeast Model of Polyglutamine Proteotoxicity

    Chemical Biology & Drug Design

    Volume 83, Issue 4, April 2014, Pages: 440–449, Gladis M. Walter, Avi Raveh, Sue-Ann Mok, Thomas J. McQuade, Carl J. Arevang, Pamela J. Schultz, Matthew C. Smith, Samuel Asare, Patricia G. Cruz, Susanne Wisen, Teatulohi Matainaho, David H. Sherman and Jason E. Gestwicki

    Version of Record online : 18 MAR 2014, DOI: 10.1111/cbdd.12259

  19. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress

    Neuropathology and Applied Neurobiology

    Volume 33, Issue 1, February 2007, Pages: 2–42, J. M. Woulfe

    Version of Record online : 12 JAN 2007, DOI: 10.1111/j.1365-2990.2006.00819.x

  20. You have free access to this content
    Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease

    Journal of Neurochemistry

    Volume 136, Issue 5, March 2016, Pages: 1052–1063, Elena R. Mikhaylova, Vladimir F. Lazarev, Alina D. Nikotina, Boris A. Margulis and Irina V. Guzhova

    Version of Record online : 11 JAN 2016, DOI: 10.1111/jnc.13463